Notably, lysine acetyltransferase 2A (KAT2A) expression is markedly increased in clear cell renal cell carcinoma (ccRCC), where it likely promotes tumour metastasis and proliferation by modulating the immune‐suppressive tumour microenvironment.32 The gene discussed is KAT2A; the disease is clear cell renal carcinoma.